Late-onset axial myopathy and camptocormia in a calpainopathy carrier

Journal of Clinical Neuromuscular Disease

Volumn 13, Issue 4, 2012, Pages 209-213

  Liewluck, Teerin ^a   Goodman, Brent P ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

axial myopathy; bent spine syndrome; calpainopathy; camptocormia; LGMD2A; limb girdle muscular dystrophy; lobulated fibers

Indexed keywords

CALPAIN 3;

AGED; ARTICLE; BLADDER CANCER; BODY POSTURE; CASE REPORT; DYSLIPIDEMIA; FATTY LIVER; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HEART ATRIUM FIBRILLATION; HUMAN; ILIOPSOAS MUSCLE; IMMUNOREACTIVITY; LOW BACK PAIN; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; BIOPSY; CALPAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR ATROPHY, SPINAL; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; SPINAL CURVATURES;

EID: 84861854621     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3182461a9c     Document Type: Article

References (32)

1. Seay AR, Ziter FA, Petajan JH. Rigid spine syndrome. A type I fiber myopathy. Arch Neurol. 1977;34: 119-122.
2. Mahjneh I, Marconi G, Paetau A, et al. Axial myopathy-an unrecognised entity. J Neurol. 2002; 249:730-734.
3. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005;65:355-359.
4. Laroche M, Delisle MB, Aziza R, et al. Is campto-cormia a primary muscular disease? Spine (Phila Pa 1976). 1995;20:1011-1016.
5. Margraf NG, Wrede A, Rohr A, et al. Camptocormia in idiopathic Parkinson's disease: a focal myopathy of the paravertebral muscles. Mov Disord. 2010;25: 542-551.
6. Sandler SA. Camptocormia or the functional bent back. Psychosom Med. 1947;9:197-204.
7. Kuo SH, Vullaganti M, Jimenez-Shahed J, et al. Camptocormia as a presentation of generalized inflammatory myopathy. Muscle Nerve. 2009;40: 1059-1063.
8. Jungbluth H, Lillis S, Zhou H, et al. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2009; 19:344-347.
9. Dupeyron A, Stober N, Gelis A, et al. Painful camptocormia: the relevance of shaking your patient's hand. Eur Spine J. 2010;19(Suppl 2): S87-S90.
10. Kottlors M, Kress W, Meng G, et al. Facioscapulo-humeral muscular dystrophy presenting with isolated axial myopathy and bent spine syndrome. Muscle Nerve. 2010;42:273-275.
11. Jordan B, Eger K, Koesling S, et al. Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol. 2010;258:866-873.
12. Laroche M, Cintas P. Bent spine syndrome (campto-cormia): a retrospective study of 63 patients. Joint Bone Spine. 2010;77:593-596.
13. Papadopoulos C, Papadimas GK, Spengos K, et al. Bent spine syndrome in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2011;43:615; author reply 615-616.
14. Sakiyama Y, Okamoto Y, Higuchi I, et al. A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy. Acta Neuropathol. 2011;121: 775-783.
15. Muppidi S, Saperstein DS, Shaibani A, et al. Isolated neck extensor myopathy: is it responsive to immu-notherapy? J Clin Neuromuscul Dis. 2010;12:26-29.
16. Saenz A, Leturcq F, Cobo AM, et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain. 2005;128:732-742.
17. Krahn M, Lopez de Munain A, Streichenberger N, et al. CAPN3 mutations in patients with idiopa-thic eosinophilic myositis. Ann Neurol. 2006;59: 905-911.
18. Burke G, Hillier C, Cole J, et al. Calpainopathy presenting as foot drop in a 41 year old. Neuro-muscul Disord. 2010;20:407-410.
19. Shirafuji T, Otsuka Y, Kobessho H, et al. Case of LGMD2A (calpainopathy) clinically presenting as Miyoshi distal myopathy [in Japanese]. Rinsho Shinkeigaku. 2008;48:651-655.
20. Angelini C, Fanin M. Calpainopathy [Gene Reviews Web site]. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1313/. Accessed September 29, 2011.
21. Chae J, Minami N, Jin Y, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord. 2001;11:547-555.
22. Charlton R, Henderson M, Richards J, et al. Immu-nohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A. Neuromus-cul Disord. 2009;19:449-457.
23. Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology. 2001; 56:1472-1481.
24. Richard I, Roudaut C, Saenz A, et al. Calpainopa-thy-a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64:1524-1540.
25. Groen EJ, Charlton R, Barresi R, et al. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain. 2007;130:3237-3249.
26. Gerton BK, Theeler B, Samii A. Backpack treatment for camptocormia. Mov Disord. 2010;25:247-248.
27. Figarella-Branger D, El-Dassouki M, Saenz A, et al. Myopathy with lobulated muscle fibers: evidence for heterogeneous etiology and clinical presentation. Neuromuscul Disord. 2002;12:4-12.
28. Pestronk A. Lobulated fibers [Neuromuscular Disease Center at Washington University Web site]. Available at: http://neuromuscular.wustl.edu/pathol/nadh. htm#lobulated. Accessed September 29, 2011.
29. Moore SA, Shilling CJ, Westra S, et al. Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol. 2006;65:995-1003.
30. Fanin M, Nascimbeni AC, Tasca E, et al. How to tackle the diagnosis of limb-girdle muscular dystrophy 2A. Eur J Hum Genet. 2009;17:598-603.
31. Fanin M, Nascimbeni AC, Angelini C. Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations. J Med Genet. 2007;44:38-43.
32. Vissing J, Sveen ML, Duno M. Dominant inheritance of limb girdle muscular dystrophy type 2A [abstract]. Neuromuscul Disord. 2011;21:750.